CoChat
Sign Up
Cited by 144

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease.

Basurto-Islas, Gustavo, Grundke-Iqbal, Inge, Tung, Yunn Chyn, Liu, Fei, Iqbal, Khalid·2013·Journal of Biological Chemistry
DOI 10.1074/jbc.m112.446070
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m112.446070

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. Cataldo, 1991, Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A, 88, 10998, 10.1073/pnas.88.24.10998 · DOI
  2. Yates, 1990, Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias, J. Neurochem, 55, 1624, 10.1111/j.1471-4159.1990.tb04948.x · DOI · Paper page
  3. Cataldo, 1990, Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease. Evidence for a neuronal origin, Brain Res, 513, 181, 10.1016/0006-8993(90)90456-L · DOI
  4. Pirchl, 2009, Does acidosis in brain play a role in Alzheimer's disease?, Neuropsychiatrie, 23, 187
  5. Bevers, 2008, Mechanistic role of calpains in postischemic neurodegeneration, J. Cereb. Blood Flow Metab, 28, 655, 10.1038/sj.jcbfm.9600595 · DOI
  6. Wen, 2008, Neuronal injury in rat model of permanent focal cerebral ischemia is associated with activation of autophagic and lysosomal pathways, Autophagy, 4, 762, 10.4161/auto.6412 · DOI
  7. Fang, 2010, Hypothesis on the relationship between the change in intracellular pH and incidence of sporadic Alzheimer's disease or vascular dementia, Int. J. Neurosci, 120, 591, 10.3109/00207454.2010.505353 · DOI
  8. Halfon, 1998, Autocatalytic activation of human legumain at aspartic acid residues, FEBS Lett, 438, 114, 10.1016/S0014-5793(98)01281-2 · DOI
  9. Li, 2003, Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo, J. Biol. Chem, 278, 38980, 10.1074/jbc.M305930200 · DOI
  10. Manoury, 1998, An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation, Nature, 396, 695, 10.1038/25379 · DOI
  11. Liu, 2003, Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy, Cancer Res, 63, 2957
  12. Clerin, 2008, Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis, Atherosclerosis, 201, 53, 10.1016/j.atherosclerosis.2008.01.016 · DOI
  13. Andrade, 2011, Nucleoplasmic calcium regulates cell proliferation through legumain, J. Hepatol, 55, 626, 10.1016/j.jhep.2010.12.022 · DOI
  14. Wu, 2010, Blastocystis legumain is localized on the cell surface, and specific inhibition of its activity implicates a pro-survival role for the enzyme, J. Biol. Chem, 285, 1790, 10.1074/jbc.M109.049064 · DOI
  15. Morita, 2007, Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells, FEBS Lett, 581, 1417, 10.1016/j.febslet.2007.02.064 · DOI
  16. Chen, 2001, Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase, Biol. Chem, 382, 777, 10.1515/bchm.2001.382.5.777 · DOI
  17. Shirahama-Noda, 2003, Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice, J. Biol. Chem, 278, 33194, 10.1074/jbc.M302742200 · DOI
  18. Liu, 2008, Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase, Mol. Cell, 29, 665, 10.1016/j.molcel.2008.02.017 · DOI
  19. Ishizaki, 2010, The asparaginyl endopeptidase legumain after experimental stroke, J. Cereb. Blood Flow Metab, 30, 1756, 10.1038/jcbfm.2010.39 · DOI
  20. Li, 1996, The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A, J. Biol. Chem, 271, 11059, 10.1074/jbc.271.19.11059 · DOI
  21. Liu, 2005, Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of Tau phosphorylation, Eur. J. Neurosci, 22, 1942, 10.1111/j.1460-9568.2005.04391.x · DOI · Paper page
  22. Gong, 1993, Phosphoprotein phosphatase activities in Alzheimer disease brain, J. Neurochem, 61, 921, 10.1111/j.1471-4159.1993.tb03603.x · DOI · Paper page
  23. Gong, 1995, Phosphatase activity toward abnormally phosphorylated Tau. Decrease in Alzheimer disease brain, J. Neurochem, 65, 732, 10.1046/j.1471-4159.1995.65020732.x · DOI
  24. Wang, 2007, Kinases and phosphatases and Tau sites involved in Alzheimer neurofibrillary degeneration, Eur. J. Neurosci, 25, 59, 10.1111/j.1460-9568.2006.05226.x · DOI
  25. Adachi, 1994, Identification and characterization of SET, a nuclear phosphoprotein encoded by the translocation break point in acute undifferentiated leukemia, J. Biol. Chem, 269, 2258, 10.1016/S0021-9258(17)42162-4 · DOI
  26. ten Klooster, 2007, Rac1-induced cell migration requires membrane recruitment of the nuclear oncogene SET, EMBO J, 26, 336, 10.1038/sj.emboj.7601518 · DOI
  27. Lam, 2012, Analysis of nucleo-cytoplasmic shuttling of the proto-oncogene SET/I2PP2A, Cytometry A, 81, 81
  28. Canela, 2003, The SET protein regulates G2/M transition by modulating cyclin B-cyclin-dependent kinase 1 activity, J. Biol. Chem, 278, 1158, 10.1074/jbc.M207497200 · DOI
  29. Seo, 2001, Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein, Cell, 104, 119, 10.1016/S0092-8674(01)00196-9 · DOI · Paper page
  30. Madeira, 2005, SET protein (TAF1β, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain, FASEB J, 19, 1905, 10.1096/fj.05-3839fje · DOI · Paper page
  31. Tanimukai, 2005, Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease, Am. J. Pathol, 166, 1761, 10.1016/S0002-9440(10)62486-8 · DOI · Paper page
  32. Arnaud, 2011, Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of Tau by I2PP2A/SET, FEBS Lett, 585, 2653, 10.1016/j.febslet.2011.07.020 · DOI
  33. Wang, 2010, The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment, FASEB J, 24, 4420, 10.1096/fj.10-158477 · DOI
  34. Bolognin, 2012, An experimental rat model of sporadic Alzheimer's disease and rescue of cognitive impairment with a neurotrophic peptide, Acta Neuropathol, 123, 133, 10.1007/s00401-011-0908-x · DOI
  35. Graham, 2001, Subcellular fractionation and isolation of organelles. Isolation of lysosomes from tissues and cells by differential and density gradient centrifugation, Curr. Protoc. Cell Biol, 3.6, 1
  36. Gong, 2001, Metabolically active rat brain slices as a model to study the regulation of protein phosphorylation in mammalian brain, Brain Res. Brain Res. Protoc, 6, 134, 10.1016/S1385-299X(00)00046-5 · DOI
  37. Chohan, 2006, Involvement of I2PP2A in the abnormal hyperphosphorylation of Tau and its reversal by Memantine, FEBS Lett, 580, 3973, 10.1016/j.febslet.2006.06.021 · DOI
  38. Grundke-Iqbal, 1986, Abnormal phosphorylation of the microtubule-associated protein Tau (τ) in Alzheimer cytoskeletal pathology, Proc. Natl. Acad. Sci. U.S.A, 83, 4913, 10.1073/pnas.83.13.4913 · DOI · Paper page
  39. Seubert, 1995, Detection of phosphorylated Ser in fetal Tau, adult Tau, and paired helical filament Tau, J. Biol. Chem, 270, 18917, 10.1074/jbc.270.32.18917 · DOI · Paper page
  40. Morgan, 1994, Possible role of tissue-bound calcium ions in citrate-mediated high-temperature antigen retrieval, J. Pathol, 174, 301, 10.1002/path.1711740410 · DOI
  41. Tsujio, 2005, Inhibitors of protein phosphatase-2A from human brain structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated Tau, FEBS Lett, 579, 363, 10.1016/j.febslet.2004.11.097 · DOI · Paper page
  42. Iqbal, 2005, Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers, Ann. Neurol, 58, 748, 10.1002/ana.20639 · DOI
  43. Alonso, 2001, Hyperphosphorylation induces self-assembly of Tau into tangles of paired helical filaments/straight filaments, Proc. Natl. Acad. Sci. U.S.A, 98, 6923, 10.1073/pnas.121119298 · DOI · Paper page
  44. Glunde, 2003, Extracellular acidification alters lysosomal trafficking in human breast cancer cells, Neoplasia, 5, 533, 10.1016/S1476-5586(03)80037-4 · DOI
  45. Back, 2000, Penumbral tissue alkalosis in focal cerebral ischemia. Relationship to energy metabolism, blood flow, and steady potential, Ann. Neurol, 47, 485, 10.1002/1531-8249(200004)47:4<485::AID-ANA12>3.0.CO;2-8 · DOI
  46. Chen, 2000, Activation of human prolegumain by cleavage at a C-terminal asparagine residue, Biochem. J, 352, 327, 10.1042/bj3520327 · DOI
  47. Nixon, 2000, The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis. A review, Neurochem. Res, 25, 1161, 10.1023/A:1007675508413 · DOI
  48. Yang, 1998, Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1–42 pathogenesis, J. Neurosci. Res, 52, 691, 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3 · DOI
  49. Castellani, 2004, Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease, Ageing Res. Rev, 3, 319, 10.1016/j.arr.2004.01.002 · DOI
  50. Li, 1995, Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney, Biochemistry, 34, 1988, 10.1021/bi00006a020 · DOI
  51. Katayose, 2000, Protein phosphatase 2A inhibitors, I1PP2A and I2PP2A, associate with and modify the substrate specificity of protein phosphatase 1, J. Biol. Chem, 275, 9209, 10.1074/jbc.275.13.9209 · DOI
  52. Turk, 1993, Kinetics of the pH-induced inactivation of human cathepsin L, Biochemistry, 32, 375, 10.1021/bi00052a046 · DOI
  53. Pivtoraiko, 2009, Oxidative stress and autophagy in the regulation of lysosome-dependent neuron death, Antioxid. Redox Signal, 11, 481, 10.1089/ars.2008.2263 · DOI
  54. Pratt, 2009, Direct measurement of cathepsin B activity in the cytosol of apoptotic cells by an activity-based probe, Chem. Biol, 16, 1001, 10.1016/j.chembiol.2009.07.011 · DOI
  55. Miura, 2010, Translocation of lysosomal cathepsin D caused by oxidative stress or proteasome inhibition in primary cultured neurons and astrocytes, Biol. Pharm. Bull, 33, 22, 10.1248/bpb.33.22 · DOI

Cited by

Sorted by citations

Metadata

Authors
Basurto-Islas, G., Grundke-Iqbal, I., Tung, Y. C., Liu, F., & Iqbal, K.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2013-06
Volume
288
Issue
24
Pages
17495-17507
ISSN
0021-9258
DOI
10.1074/jbc.m112.446070
Cited by
144
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review